Biocon Limited.Pharmaceuticals | Biocon Biologics gets Japan approval for Pegfilgrastim biosimilar25 Aug 2026Regulatory Product Approval×5 | +2.0% -1.7% -6.6% | ₹350 | 57,039 Cr | 102.9vs 31.2 | 0.9% | +10.0% |
Jubilant PharmovaPharmaceuticals | USFDA approves Line 3 at Spokane contract manufacturing facility23 Aug 2026Regulatory Product Approval | +2.1% +2.6% +21.3% | ₹939 | 14,930 Cr | 42.2vs 31.2 | 4.7% | +17.3% |
Mamata MachineryIndustrial Products | Patent granted for Quadra 600 machine BOPP bag technology21 Aug 2026Regulatory Product Approval | -1.7% -4.7% -4.6% | ₹385 | 946 Cr | 105.9vs 28.5 | 10.1% | -90.6% |
Glenmark PharmaceuticalsPharmaceuticals | Glenmark's US arm launches Calcium Gluconate Injection in US market21 Aug 2026Regulatory Product Approval×4 | +2.5% +5.2% +5.4% | ₹2,192 | 61,864 Cr | 34.4vs 31.2 | 14.7% | +23.1% |
Anant RajResidential Commercial Projects | Anant Raj gets RERA registration for Gurugram luxury housing project20 Aug 2026Regulatory Product Approval | -3.1% -7.5% -6.0% | ₹584 | 21,018 Cr | 35.4vs 20.8 | 10.2% | +6.6% |
Titagarh Rail SystemsRailway Wagons | Vendor approval for 3-Phase Locomotive Traction Motor from Indian Railways19 Aug 2026Regulatory Product Approval | +1.8% -1.5% +1.2% | ₹779 | 10,485 Cr | 54.9 | 7.4% | +12.6% |
Strides Pharma SciPharmaceuticals | Strides gets USFDA clearance for Bengaluru plant19 Aug 2026Regulatory Product Approval | +3.0% +7.7% +28.8% | ₹1,080 | 9,955 Cr | 16.2vs 31.2 | 16.6% | +13.0% |
Iirm Holdings IndiaConsulting Services | Subsidiary gets IRDAI registration as Corporate Agent19 Aug 2026Regulatory Product Approval | -0.2% -2.1% +5.7% | ₹118 | 804 Cr | 32.8vs 8.9 | 14.4% | +8.2% |
Centum ElectronicsAerospace & Defense | ECMS approval for Rs. 106 crore investment in Transducers and Filters18 Aug 2026Regulatory Product Approval | +0.4% -0.1% +37.9% | ₹4,154 | 6,131 Cr | 114.7vs 73.9 | 18.0% | -25.3% |
Permanent MagnetsOther Electrical Equipment | Subsidiary Quantum Magnetics gets ECMS approval for Neodymium magnets18 Aug 2026Regulatory Product Approval | +9.0% +9.3% +3.8% | ₹853 | 734 Cr | 48.6vs 24.6 | 9.3% | +47.0% |
OmaxeResidential Commercial Projects | Omaxe gets RERA nod for PDA Omaxe City Commercial project in Patiala18 Aug 2026Regulatory Product Approval×2 | +1.1% +30.9% +12.2% | ₹98.4 | 1,800 Cr | — | -105.0% | +43.9% |
Colgate PalmolivePersonal Care | Colgate PerioGard earns ISP Seal of Acceptance — first in India18 Aug 2026Regulatory Product Approval | +0.4% -3.9% -1.2% | ₹1,736 | 47,211 Cr | 35.0vs 35.6 | 107.1% | +11.8% |
PCBL ChemicalCarbon Black | PCBL gets ECMS approval for Acetylene Black Project worth Rs 329 cr18 Aug 2026Regulatory Product Approval | +2.9% +2.3% +7.0% | ₹320 | 12,592 Cr | 48.2 | 3.4% | +17.0% |
MAN Industries (I)Iron & Steel Products | Man Industries wins PML approval from QatarEnergy for LSAW pipes14 Aug 2026Regulatory Product Approval | +8.0% +22.1% +39.6% | ₹858 | 6,433 Cr | 31.0vs 17.0 | 9.8% | +41.9% |
Prithvi Exchange (India) LimitOther Financial Services | RBI grants Perpetual AD-II License to Prithvi Exchange13 Aug 2026Regulatory Product Approval | -1.0% -5.8% +1.7% | ₹100 | 83 Cr | 29.7vs 21.0 | 6.2% | +29.4% |
FDCPharmaceuticals | FDC subsidiary gets UK MHRA approval for Atropine eye drops13 Aug 2026Regulatory Product Approval | +0.3% -3.0% -1.4% | ₹325 | 5,289 Cr | 18.1vs 31.2 | 14.7% | +3.0% |
Speciality MedicinesPharmaceuticals | Speciality Medicines gets approval for 2 new products in Ethiopia12 Aug 2026Regulatory Product Approval | +1.6% -0.6% +1.7% | ₹190 | 167 Cr | 15.2vs 31.2 | 17.0% | — |
Bajaj HealthcarePharmaceuticals | Bajaj Healthcare gets DCGI nod to launch Cenobamate API and Tablets in India12 Aug 2026Regulatory Product Approval | +0.5% -1.8% -1.8% | ₹314 | 1,057 Cr | 58.1vs 31.2 | 4.8% | +11.3% |
Dachepalli PublishersPrinting & Publication | Dachepalli Publishers launches PageCraft notebook brand and school kits11 Aug 2026Regulatory Product Approval | -2.0% — +10.1% | ₹97.05 | 145 Cr | 7.8vs 7.4 | 18.2% | — |
Zydus LifesciencesPharmaceuticals | Zydus launches REVAHALE, India's first once-daily nebulised LAMA for COPD10 Aug 2026Regulatory Product Approval×2 | +7.2% -1.0% +0.2% | ₹1,112 | 1.11 L Cr | 24.8vs 31.2 | 18.0% | +22.0% |
MAN InfraResidential Commercial Projects | MICL Group gets IOA for Bandra luxury project with 1000+ crore GDV10 Aug 2026Regulatory Product Approval | -2.2% -3.3% +13.1% | ₹118 | 4,762 Cr | 22.0vs 20.8 | 11.4% | +19.4% |
Astrazeneca Pharma IndPharmaceuticals | AstraZeneca India gets CDSCO nod for Enhertu additional indication8 Aug 2026Regulatory Product Approval×3 | -3.2% -8.5% -16.5% | ₹5,715 | 14,288 Cr | 84.2vs 31.2 | 25.0% | +29.7% |
GEEOther Electrical Equipment | GEE Limited gets NPCIL vendor approval for nuclear power supply chain6 Aug 2026Regulatory Product Approval | +10.6% +20.3% +18.6% | ₹119 | 618 Cr | 24.4vs 24.6 | 7.8% | +27.5% |
Steel City SecuritiesStockbroking & Allied | Steel City Securities gets Market Maker approval from NSE and BSE4 Aug 2026Regulatory Product Approval | -2.5% -3.9% -2.1% | ₹79.81 | 121 Cr | 7.0vs 15.8 | 13.8% | +28.5% |
DelhiveryLogistics Solution Provider | RBI grants NBFC registration to Delhivery Financial Services subsidiary4 Aug 2026Regulatory Product Approval×2 | -0.9% -1.4% -3.5% | ₹397 | 29,729 Cr | 317.6vs 15.7 | 1.2% | +27.8% |
GUJ NAR VAL FER & ChemCommodity Chemicals | GNFC Gets Positive Rs 61 Crore Impact from Revised Urea Energy Norms1 Aug 2026Regulatory Product Approval | +1.8% +7.8% +15.0% | ₹599 | 8,806 Cr | 8.5vs 18.9 | 10.3% | +39.8% |
Keto Motors | Keto Motors launches Urbanova KE9 electric bus1 Aug 2026Regulatory Product Approval×3 | pending | ₹232 | 1,634 Cr | — | -0.3% | — |
Ashiana HousingResidential Commercial Projects | July 2026 ops: Bookings at 501.76 Cr, OCs received for Gurugram projects1 Aug 2026Regulatory Product Approval | -1.0% -3.8% -6.1% | ₹370 | 3,719 Cr | 30.7vs 20.8 | 13.1% | -63.3% |
WSFX Global PayFinancial Technology (Fintech) | WSFX Global Pay gets perpetual RBI AD-II licence with expanded scope31 Jul 2026Regulatory Product Approval | +3.7% +9.3% +0.7% | ₹61 | 77 Cr | — | -6.4% | +58.9% |
MAS Financial ServNon Banking Financial Company (NBFC) | MAS Financial gets UIDAI approval for Aadhaar authentication services31 Jul 2026Regulatory Product Approval | -2.6% -4.5% -8.2% | ₹265 | 4,808 Cr | 12.2vs 18.9 | — | +20.7% |
Fischer Medical VentureMedical Equipment & Supplies | Fischer Medical Ventures Gets CDSCO Import Approval for Spincare System30 Jul 2026Regulatory Product Approval | +7.5% +9.6% -1.2% | ₹32 | 2,094 Cr | 13.3vs 21.9 | 11.3% | +249.4% |
Sun Pharmaceutical IndPharmaceuticals | Sun Pharma gets Brazil approval to market semaglutide for diabetes29 Jul 2026Regulatory Product Approval×4 | -0.3% -2.4% -0.3% | ₹1,760 | 4.22 L Cr | 34.9vs 31.2 | 17.5% | +10.5% |
Dr. Reddy S LaboratoriesPharmaceuticals | Dr Reddy's confirms Thailand approval for gonorrhoea drug NUZOLVENCE29 Jul 2026Regulatory Product Approval | +0.9% +3.0% +1.7% | ₹1,180 | 98,530 Cr | 30.5vs 31.2 | 13.0% | -5.5% |
Alembic PharmaPharmaceuticals | Alembic Pharma gets USFDA nod for Prucalopride Tablets 1mg and 2mg28 Jul 2026Regulatory Product Approval×2 | -0.7% +2.4% -0.1% | ₹800 | 15,724 Cr | 22.7vs 31.2 | 11.2% | +25.7% |
Meghna Infracon InfraResidential, Commercial Projects | Meghna Infracon delivers Riviera project in Goregaon in 16 months28 Jul 2026Regulatory Product Approval | -0.4% -3.0% — | ₹668 | 1,451 Cr | 214.1vs 18.4 | 33.9% | +52.5% |
CiplaPharmaceuticals | Cipla gets US FDA approval for Generic Advair Diskus27 Jul 2026Regulatory Product Approval | +4.2% +4.4% 0.0% | ₹1,307 | 1.06 L Cr | 31.3vs 31.2 | 14.7% | +2.3% |
Supreme Holdin N Hosp IResidential Commercial Projects | CIDCO approves 3 extra floors at Belmac Infinity, project revised from G+10 to G+1327 Jul 2026Regulatory Product Approval | +0.9% +2.0% -12.7% | ₹29.56 | 114 Cr | 155.6vs 20.8 | 0.1% | +1284.1% |
Goodluck IndiaIron & Steel Products | Subsidiary Gets Defence Quality Certification for Artillery Shells27 Jul 2026Regulatory Product Approval | +0.2% +0.5% -70.6% | ₹495 | 1,644 Cr | 7.9vs 17.0 | 13.5% | +30.9% |
EbixHotels & Resorts | EbixCash Wallet Integrates with BHIM UPI27 Jul 2026Regulatory Product Approval | +1.6% -7.0% — | ₹16.87 | 349 Cr | 1.1vs 27.3 | -9.2% | -5.1% |
Indo Tech TransformINDOTECH | Enters 400 kV transformer segment with NTPC approval and initial order24 Jul 2026Regulatory Product Approval | +1.9% +5.6% +9.4% | ₹3,155 | 3,351 Cr | 33.7 | 32.4% | +39.0% |